The study aimed to determine if suppressing hepatic UGT1A1 with GNUR could increase plasma bilirubin levels and reduce hepatic lipid accumulation and inflammation in a murine model of dietary-induced NAFLD. This evidence concerns the gene UGT1A1 and metabolic dysfunction-associated steatotic liver disease.